1 Tech, 1 Biotech And 1 Business Services Company With Recent Intensive Insider Selling
5/23/2013 2:44:00 PM - Seeking Alpha
Vertex Pharma To Present At Bank Of America Conference; Webcast At 6:40 PM ET
5/14/2013 3:00:00 PM - RTT News
This Stock Deserved Its Sudden Upswing
5/13/2013 2:31:00 AM - Seeking Alpha
Vertex Debt Conversion Is Not Bad For Shareholders
5/9/2013 3:25:00 AM - Seeking Alpha
Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential
5/3/2013 10:18:00 PM - Seeking Alpha
Vertex Pharmaceuticals Beats Analyst Expectations, Yet Insiders Continue To Sell More Shares
5/3/2013 7:54:00 AM - Seeking Alpha
Why BioMarin, Catalyst Pharmaceutical Partners And Vertex Are Expected To Outperform
5/1/2013 11:17:00 AM - Seeking Alpha
Vertex Loss Lower, Kalydeco Outlook Up - Analyst Blog
5/1/2013 8:49:18 AM - Zacks.com
U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH -2-
5/1/2013 8:42:00 AM - Dow Jones Business News
Benzinga Market Primer: Wednesday, May 1
5/1/2013 6:37:37 AM - Benzinga
UPDATE: Vertex Pharmaceuticals Swings to 1st-Quarter Loss on Write-Down
4/30/2013 6:58:00 PM - Dow Jones Business News
Vertex Swings To Q1 Loss
4/30/2013 5:52:00 PM - RTT News
Vertex Pharmaceuticals Swings to 1st-Quarter Loss on Write-Down
4/30/2013 4:47:00 PM - Dow Jones Business News
Vertex Pharmaceuticals Q1 13 Earnings Conference Call At 5:00 PM ET
4/30/2013 3:03:00 PM - RTT News
After-Hours Earnings Report for April 30, 2013 : EQR, VRTX, AVB, BXP, FISV, OKE, VRSK, AUY, FMC, WU, OKS, TRMB
4/30/2013 2:00:04 PM - NASDAQ.com News
Benzinga Market Primer: Tuesday, April 30
4/30/2013 6:38:40 AM - Benzinga
NewLink Genetics: Looking To Join The Industry's Largest Movers
4/29/2013 5:51:00 AM - Seeking Alpha
UPDATE: FDA Gives 'Breakthrough' Designation to Merck Skin-Cancer Drug
4/24/2013 10:10:00 AM - Dow Jones Business News
Vertex Pharma Reports Interim Analysis Data Of Phase 3b CONCISE Trial
4/24/2013 9:42:00 AM - RTT News
Cramer's Lightning Round - EMC Is Controversial (4/23/13)
4/24/2013 6:45:00 AM - Seeking Alpha
Vertex Spikes On Phase II Data, Then The CFO Sell His Shares
4/24/2013 1:50:00 AM - Seeking Alpha
FDA Gives 'Breakthrough' Designation to Merck Skin-Cancer Drug
4/23/2013 9:15:00 PM - Dow Jones Business News
Merck - BMY in HCV Deal - Analyst Blog
4/23/2013 6:09:40 PM - Zacks.com
Vertex Pharma Says VX-135 Holds Promise For Hepatitis C
4/23/2013 9:52:00 AM - RTT News
Catalyst Deserves The Attention
4/23/2013 4:43:00 AM - Seeking Alpha
